imatinib mesylate has been researched along with Brain Hemorrhage in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aleem, A; AlFaifi, A; Alotaibi, G; Iqbal, Z | 1 |
| Borges, LF; Cahill, DP; Kahle, KT; Nahed, BV; Naunheim, MR; Soupir, CP; Walcott, BP | 1 |
| Bojanowski, MW; Guiot, MC; Mercier, F | 1 |
1 review(s) available for imatinib mesylate and Brain Hemorrhage
| Article | Year |
|---|---|
Diagnosis of acute lymphoblastic leukemia from intracerebral hemorrhage and blast crisis. A case report and review of the literature.
Topics: Benzamides; Blast Crisis; Blood Cell Count; Diagnosis, Differential; Flow Cytometry; Humans; Imatinib Mesylate; In Situ Hybridization; Intracranial Hemorrhages; Leukemia, Biphenotypic, Acute; Leukocyte Count; Male; Middle Aged; Piperazines; Pyrimidines; Tomography, X-Ray Computed | 2010 |
2 other study(ies) available for imatinib mesylate and Brain Hemorrhage
| Article | Year |
|---|---|
Eltrombopag for tyrosine kinase inhibitors-associated thrombocytopenia in chronic myeloid leukemia.
Topics: Female; Humans; Imatinib Mesylate; Intracranial Hemorrhages; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Thrombocytopenia; Treatment Outcome; Tyrosine Kinase Inhibitors | 2023 |
Treatment of chordoma with imatinib complicated by intracranial hemorrhage: a case showing dissociation between biological effect and therapeutic outcome.
Topics: Adult; Antineoplastic Agents; Benzamides; Brain Neoplasms; Chordoma; Female; Humans; Imatinib Mesylate; Intracranial Hemorrhages; Magnetic Resonance Imaging; Piperazines; Pyrimidines; Tomography, X-Ray Computed | 2012 |